Skip to content
PainCeptor logo — company profile

PainCeptor

Founded 2004 Canada Canada 1 employees Series B Total: $41.60M Health and Wellness, Pharmaceutical

General Information

Company Name PainCeptor
Founded Year 2004
Location Canada Canada
Employees 1
Industries Health and Wellness, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with PainCeptor. To contact PainCeptor, visit painceptor.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PainCeptor compare?

A PDF of PainCeptor and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PainCeptor soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PainCeptor

PainCeptor Pharma Corporation, a Canadian-based private biopharmaceutical company founded in 2004, specializes in developing safe and effective pharmaceuticals for managing chronic and acute pain. Their unique approach focuses on highly-selective organic molecules designed to intercept pain signals directly at the source.

Operating in the Health and Wellness and Pharmaceutical industries, PainCeptor has established a strong reputation for leveraging cutting-edge research and industrial collaborations to address unmet needs in pain management for debilitating diseases.

As of March 7, 2007, PainCeptor received a $24.40M Series B investment from a consortium of investors, including Lothian Partners, Desjardins Venture Capital, the Business Development Bank of Canada, and CDP Capital Technology Ventures. This funding bolstered PainCeptor's capability to advance its innovative pipeline and expand its market foothold.

Business keywords: Biopharmaceuticals, Pain management, Drug development, Chronic pain, Acute pain, Organic molecules, Pain relief, Therapeutics, Pain signals, Pharmaceutical research, Canadian company

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $24.40M 4
Lothian Partners, Desjardins Venture Capital +2
07 Mar 2007
Series A $17.20M 1
CDP Capital Technology Ventures
22 Mar 2004

PainCeptor Alternatives & Competitors

View All Alternatives
PainCeptor vs
Baudax Bio
Baudax Bio United States

Advancing Acute Care Therapeutics

Post-IPO Equity
12 employees
Biotechnology, Health and Wellness
PainCeptor vs

First in class small molecules pushing cancer cells to burn out

Debt Financing
7 employees
Biotechnology, Health and Wellness
PainCeptor vs

Alphyn develops first-in-class, multi-target therapeutics for atopic dermatitis & other severe and c...

Venture round
4 employees
Health Care, Health and Wellness

FAQ About PainCeptor

PainCeptor Pharma Corporation is a Canadian-based, private biopharmaceutical company focused on the development of safe, effective and peripherally-active pharmaceuticals for the management of chronic and acute pain. Our researchers and industrial collaborators maintain a leadership position in t...
PainCeptor was founded in 2004.
PainCeptor is headquartered in Canada.
PainCeptor operates in Health and Wellness and Pharmaceutical. Its work centres on Biopharmaceuticals, Pain management, Drug development and Chronic pain.
PainCeptor has approximately 1 employees.
PainCeptor has completed 2 funding rounds, raising a total of $41.60M. The latest funding stage is Series B.
Top alternatives and competitors to PainCeptor include Baudax Bio, BiPER Therapeutics, Alphyn Biologics, Inc., Acticor Biotech, NeuroTherapia, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PainCeptor and Baudax Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PainCeptor, https://bouncewatch.com/company/painceptor, updated 26 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout